Description:

This study is seeking COVID-19 positive adults between the aged 40 and older to help evaluate the effectiveness of a new oral medication for treatment. There are 8 visits in this study in a period of 24 weeks.

Qualified Participants have: 

• Patients aged 18 and older

• A positive SARS-CoV-2 test no more than 1 day before study entry 

• At least 2 COVID symptoms that began no more than 3 days before study entry 

Location:

6210 Brandt Pike, Suite 102

Dayton, Ohio 45424

(937) 912-4369